Gyre Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	690	642	1,038	1,967	-
Market Cap Growth	-1.94%	-38.21%	-47.22%	-	-
Enterprise Value	649	618	1,050	1,946	-
Last Close Price	7.67	7.06	12.10	25.69	-
PE Ratio	139.32	127.65	85.93	-	-
PS Ratio	6.01	5.50	9.82	17.34	-
PB Ratio	6.61	4.51	10.55	25.07	-
P/TBV Ratio	7.01	6.43	16.85	-	-
P/FCF Ratio	-	-	-	113.23	-
P/OCF Ratio	693.44	635.33	-	75.99	-
EV/Sales Ratio	5.57	5.30	9.93	17.15	-
EV/EBITDA Ratio	46.31	44.13	58.96	95.72	-
EV/EBIT Ratio	56.47	53.81	64.73	101.27	-
EV/FCF Ratio	-	-	-	111.99	-
Debt / Equity Ratio	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.06	0.06	0.09	0.02	0.06
Debt / FCF Ratio	-	-	-	0.02	0.11
Net Debt / Equity Ratio	-0.36	-0.36	-0.25	-0.42	-0.34
Net Debt / EBITDA Ratio	-3.67	-3.67	-1.41	-1.63	-2.38
Net Debt / FCF Ratio	286.03	286.03	4.21	-1.90	-4.32
Asset Turnover	0.80	0.80	0.87	1.13	-
Inventory Turnover	0.66	0.66	0.73	0.89	-
Quick Ratio	4.58	4.58	2.64	2.49	3.33
Current Ratio	5.60	5.60	3.32	2.85	4.06
Return on Equity (ROE)	8.21%	8.21%	20.24%	-113.45%	-
Return on Assets (ROA)	4.93%	4.93%	8.38%	11.93%	-
Return on Invested Capital (ROIC)	9.29%	9.58%	21.08%	41.30%	8.85%
Return on Capital Employed (ROCE)	7.80%	7.80%	15.30%	19.90%	12.70%
Earnings Yield	0.72%	0.78%	1.16%	-4.72%	-
FCF Yield	-0.03%	-0.03%	-0.57%	0.88%	-
Buyback Yield / Dilution	-0.87%	-0.87%	-55.39%	13.02%	-

Source: S&P Capital IQ. Standard template. Financial Sources.